Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28759
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFogarty, Tamara-
dc.contributor.authorTacey, Mark A-
dc.contributor.authorMcCorkell, Giulia-
dc.contributor.authorKok, David-
dc.contributor.authorHornby, Colin-
dc.contributor.authorMilne, Roger L-
dc.contributor.authorMillar, Jeremy-
dc.contributor.authorForoudi, Farshad-
dc.contributor.authorOng, Wee Loon-
dc.date2022-02-01-
dc.date.accessioned2022-02-11T03:19:45Z-
dc.date.available2022-02-11T03:19:45Z-
dc.date.issued2022-08-
dc.identifier.citationJournal of Medical Imaging and Radiation Oncology 2022; 66(5): 678-687en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28759-
dc.description.abstractTo describe the pattern of the use of advanced radiation therapy (RT) techniques, including intensity-modulated RT (IMRT), volumetric modulated arc therapy (VMAT), and stereotactic body RT (SBRT) for the management of bone metastases (BM), and the associated factors in Victoria. We used a population-based cohort of patients from the state-wide Victorian Radiotherapy Minimum Data Set (VRMDS) who received RT for BM between 2012 and 2017. The primary outcome was proportion of RT courses using advanced RT techniques. The Cochran-Armitage test for trend was used to evaluate temporal trend in advanced RT use. Multinomial logistic regression was used to identify factors associated with advanced RT use. A total of 18,158 courses of RT were delivered to 10,956 patients-16,626 (91.6%) courses were 3D conformal RT, 857 (4.7%) IMRT/VMAT and 675 (3.7%) SBRT. There was a sharp increase in IMRT/VMAT use from <1% in 2012-2015, to 10.1% in 2016 and 16.3% in 2017 (P-trend < 0.001). Increase in SBRT use was more gradual, from 1.2% in 2012 to 4.8% in 2016 and 5.5% in 2017 for SBRT (P-trend<0.001). In multivariate analyses, year of RT was the strongest predictor of IMRT/VMAT use (OR = 41; 95%CI = 25-67; P < 0.001, comparing 2012-2013 and 2016-2017). Primary tumour type (prostate cancer) was the strongest predictor of SBRT use (OR = 6.07; 95% CI = 4.19-8.80; P < 0.001). Overall, there was increasing trend in the use of advanced RT techniques for BM in Victoria, with a distinct pattern for IMRT/VMAT compared with SBRT - SBRT uptake was more gradual while IMRT/VMAT uptake was abrupt, occurring contemporaneously with Medicare Benefit Scheme funding changes in 2016.en
dc.language.isoeng-
dc.subjectIMRTen
dc.subjectVMATen
dc.subjectbone metastasesen
dc.subjectradiation therapyen
dc.subjectstereotacticen
dc.titlePatterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Medical Imaging and Radiation Oncologyen
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen
dc.identifier.affiliationDepartment of Epidemiology and Preventive Medicine, Monash University, Prahran, Victoria, Australiaen
dc.identifier.affiliationMelbourne Medical School, University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationCancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australiaen
dc.identifier.affiliationPrecision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australiaen
dc.identifier.affiliationCentral Clinical School, Monash University, Prahran, Victoria, Australiaen
dc.identifier.affiliationDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australiaen
dc.identifier.affiliationSchool of Clinical Medicine, University of Cambridge, Cambridge, UKen
dc.identifier.affiliationVictorian Department of Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Radiation Oncology, Alfred Health, Melbourne, Victoria, Australiaen
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35106919/en
dc.identifier.doi10.1111/1754-9485.13381en
dc.type.contentTexten
dc.identifier.orcid0000-0002-3383-4656en
dc.identifier.orcid0000-0001-8387-0965en
dc.identifier.orcid0000-0001-6657-7193en
dc.identifier.orcid0000-0003-2948-8495en
dc.identifier.pubmedid35106919-
local.name.researcherForoudi, Farshad
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptRadiation Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptRadiation Oncology-
crisitem.author.deptRadiation Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

52
checked on Dec 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.